LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Celebrating bioeconomy and biotechnology on DNA Day and Earth Day

    27/04/2023

    BLOG POST

    by Lucie McMurtry, Industrial Biotechnology Manager, EuropaBio

    DNA Day is celebrated on 25 April and this year marked 70 years since the publication of the structure of the DNA molecule in 1953 by James Watson, Francis Crick and Rosalind Franklin in 1953[1]. In addition to being one of the most notable scientific discoveries of the 20th centuries, unravelling the structure of DNA also paved the way for the development of biotechnology in research and industry. Our understanding of DNA enabled us to develop solutions for human health; improved access to the quality and quantity of food and feedstuffs and supports the move towards a bio-based and zero-waste economy.

    Opportunities of the bioeconomy

    Also on 25 April 2023, the Council of the EU approved conclusions on the opportunities of the bioeconomy to promote a more sustainable, competitive, and resilient Europe[2]. In particular, the conclusions note that the bioeconomy can play a key role towards achieving the EU Green Deal’s environmental and climate goals, while also being crucial for European competitiveness and food security. The key role of research and innovation and the need to improve the alignment between scientific advances and industry policy was also stressed.

    Bioeconomy refers to the use of renewable biological resources (biomass) from land and sea, such as crops, forest products, fish, animals, and micro-organisms, to produce food, materials, and energy. Biotechnology, on the other hand, integrates life sciences and engineering to support the development of biomanufacturing processes at scale. Like the double strands of a DNA molecule, biotechnology and the bioeconomy are two parts of a whole. Biotechnology is a key enabler for the bioeconomy, while the bioeconomy provides the foundation for a value chain in which biotechnology can play a role from start to finish.

    Europe was a global forerunner in developing the bioeconomy, publishing its first Bioeconomy Strategy in 2012, and an updated version in 2018. While these strategies predate the Green Deal, it is crucial to continue building on their momentum to ensure policy coherence between EU goals on bioeconomy and relevant Green Deal initiatives, in particular those relating to circular economy and food systems. This is recognised in the Council conclusions, which correctly call on the Commission to “better integrate bioeconomy into all policies and ensure policy coherence” as well as to update the EU Bioeconomy Strategy and associated action plan.  

    Investing in our planet

    Other than coinciding with the Council meeting, DNA Day also falls in the same week as Earth Day, which in 2023 has the theme “Invest in our Planet”. While the structure of DNA may seemingly have little to do with environmental protection, biotechnology, and the bioeconomy more broadly, can do much to support environmental and climate goals.  

    The United States recently announced an Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy[3] which aims to grow the US economy while improving quality of life and of the environment. As part of this, the Biden administration has outlined bold goals for biomanufacturing and biotechnology targets linked to climate change solutions, food and agriculture innovation, supply chain resilience, human health, and further cross-cutting advances. [4] Some examples of the targets outlined include making at least 30% of chemicals through biomanufacturing processes and displacing more than 90% of plastics and commercial polymers through recyclable-by-design polymers produced from bio-based feedstocks. These ambitions are supported by over $1 billion in funding from the Defense Department[5].

    A broader US initiative addressing climate goals is the Inflation Reduction Act (IRA), which offers funding, programs, and incentives to reduce greenhouse gas emissions and accelerate the transition to a clean energy economy[6]. The EU response to the US IRA is seen as the Green Deal Industrial Plan (GDIP), which aims enhance the competitiveness of Europe's net-zero industry and support the fast transition to climate neutrality.[7]

    As part of the GDIP, the recently published Net-Zero Industry Act (NZIA) is seen as a critical tool for the EU green transition and strategic autonomy. However, despite announcing that the NZIA establishes a framework of measures for strengthening Europe’s net-zero technology products manufacturing ecosystem, it focuses narrowly on renewable energy technologies[8]. The rest of the manufacturing ecosystem, including biomanufacturing, is excluded.

    The narrow focus of the NZIA might make sense when considering the scope of the US IRA. However, beyond defossilising our energy supply and ensuring its resilience, it is crucial to also consider the efficiency and overall impact of our industrial and manufacturing production processes as a key component of our net-zero ambitions. The update to the EU Bioeconomy Strategy called for in the Council conclusions should therefore aim to be as bold as the US Executive Order in order to support the double strands of bioeconomy and biotechnology and to invest in our planet.

     

    [1] https://www.genome.gov/dna-day
    [2] https://www.consilium.europa.eu/en/press/press-releases/2023/04/25/promoting-a-more-sustainable-competitive-and-resilient-europe-and-boosting-rural-areas-council-approves-conclusions-on-the-opportunities-of-the-bioeconomy/#:~:text=The%20need%20to%20promote%20the,opportunities%20offered%20by%20the%20bioeconomy%E2%80%9D.
    [3] https://www.whitehouse.gov/briefing-room/presidential-actions/2022/09/12/executive-order-on-advancing-biotechnology-and-biomanufacturing-innovation-for-a-sustainable-safe-and-secure-american-bioeconomy/
    [4] https://www.whitehouse.gov/wp-content/uploads/2023/03/Bold-Goals-for-U.S.-Biotechnology-and-Biomanufacturing-Harnessing-Research-and-Development-To-Further-Societal-Goals-FINAL.pdf
    [5] https://www.bloomberg.com/news/articles/2023-03-22/biden-aims-to-replace-chemicals-fuels-with-biological-products-in-global-race?leadSource=uverify%20wall#xj4y7vzkg
    [6] https://www.epa.gov/green-power-markets/inflation-reduction-act#:~:text=Most%20provisions%20of%20the%20Inflation,%2C%20local%2C%20and%20tribal%20organizations.
    [7] https://ec.europa.eu/commission/presscorner/detail/en/ip_23_510
    [8] The eight technologies identified in the Annex include: Solar photovoltaic and solar thermal technologies; onshore wind and offshore renewable technologies; battery/storage technologies; heat pumps and geothermal energy technologies; electrolysers and fuel cells; sustainable biogas/biomethane technologies; carbon capture and storage (CCS) technologies; and grid technologies.
    Share
    Communications Team
    Communications Team

    Related posts

    08/05/2026

    Technovative Solutions Ltd. joins EuropaBio: Advancing AI‑Driven and Sustainable Innovation in Biotechnology


    Read more
    23/04/2026

    ITRE’s recognition of the importance of biomanufacturing and of biotechnology as a horizontal enabling technology for Europe’s future in the European Competitiveness Fund


    Read more
    22/04/2026

    EuropaBio Consultation Response: Review of the EU Taxonomy Delegated Acts


    Read more

    Important links

    • Technovative Solutions Ltd. joins EuropaBio: Advancing AI‑Driven and Sustainable Innovation in Biotechnology
    • ITRE’s recognition of the importance of biomanufacturing and of biotechnology as a horizontal enabling technology for Europe’s future in the European Competitiveness Fund

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.